"Progestins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
| Descriptor ID |
D011372
|
| MeSH Number(s) |
D27.505.696.399.472.858
|
| Concept/Terms |
Progestins- Progestins
- Progestagens
- Progestational Hormones
- Progestogens
- Gestagen
- Progestational Compounds
- Progestagenic Agents
- Gestagenic Agents
- Progestin
- Gestagens
- Progestational Agents
Progestin Effect- Progestin Effect
- Effect, Progestin
- Progestogen Effect
- Effect, Progestogen
- Gestagenic Effects
- Effects, Gestagenic
- Gestagen Effect
- Effect, Gestagen
- Gestagen Effects
- Effects, Gestagen
- Gestagenic Effect
- Effect, Gestagenic
- Progestin Effects
- Effects, Progestin
- Progestogen Effects
- Effects, Progestogen
|
Below are MeSH descriptors whose meaning is more general than "Progestins".
Below are MeSH descriptors whose meaning is more specific than "Progestins".
This graph shows the total number of publications written about "Progestins" by people in this website by year, and whether "Progestins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2009 | 3 | 0 | 3 |
| 2010 | 1 | 1 | 2 |
| 2011 | 3 | 0 | 3 |
| 2012 | 1 | 2 | 3 |
| 2013 | 2 | 1 | 3 |
| 2014 | 2 | 1 | 3 |
| 2015 | 1 | 3 | 4 |
| 2016 | 1 | 2 | 3 |
| 2017 | 2 | 2 | 4 |
| 2018 | 3 | 1 | 4 |
| 2019 | 4 | 1 | 5 |
| 2020 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 3 | 3 |
| 2023 | 1 | 2 | 3 |
| 2024 | 2 | 0 | 2 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Progestins" by people in Profiles.
-
Boelig RC, Tersigni C, Di Simone N, Saccone G, Facchinetti F, Scambia G, Berghella V. Cerclage in singleton pregnancies with no prior spontaneous preterm birth and short cervix: a randomized controlled trial. Am J Obstet Gynecol MFM. 2025 Apr; 7(4):101602.
-
Williams CE, Boelig RC. Vaginal progesterone for prevention of preterm birth in women with a history of preterm birth regardless of cervical length: an argument for use. Am J Obstet Gynecol MFM. 2025 Mar; 7(1S):101565.
-
Tolosa JE, Boelig RC, Bell J, Mart?nez-Baladejo M, Stoltzfus J, Mateus J, Qui?ones JN, Galeano-Herrera S, Pereira L, Burwick R, L?pez-Torres L, Valencia C, Berghella V. Concurrent progestogen and cerclage to reduce preterm birth: a multicenter international retrospective cohort. Am J Obstet Gynecol MFM. 2024 07; 6(7):101351.
-
Rana T, Gulersen M, Roman A, Boelig RC, Berghella V. Reply to Letter to Editor 'Vaginal progesterone should be offered to patients with a singleton gestation and a history of spontaneous preterm birth only if a cervical length =25 mm is detected at midtrimester'. Am J Obstet Gynecol MFM. 2024 01; 6(1):101216.
-
Berghella V, Gulersen M, Roman A, Boelig RC. Vaginal progesterone for the prevention of recurrent spontaneous preterm birth. Am J Obstet Gynecol MFM. 2023 10; 5(10):101116.
-
Boelig RC. Obstetric Indications for Progestin Therapy. Obstet Gynecol Clin North Am. 2023 Mar; 50(1):101-107.
-
Boelig RC, Locci M, Saccone G, Gragnano E, Berghella V. Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2022 09; 4(5):100658.
-
Leon-Martinez D, Bank TC, Lundsberg LS, Culhane J, Silasi M, Son M, Partridge C, Reddy UM, Hoffman MK, Merriam AA. Does Antenatal Progesterone Administration Modify the Risk of Neonatal Intraventricular Hemorrhage? Am J Perinatol. 2024 05; 41(S 01):e46-e52.
-
Boelig RC, Schoen CN, Frey H, Gimovsky AC, Springel E, Backley S, Berghella V. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial. Am J Obstet Gynecol. 2022 05; 226(5):722.e1-722.e12.
-
Boelig RC, Kripalu V, Chen SL, Cruz Y, Roman A, Berghella V. Utility of follow-up cervical length screening in low-risk women with a cervical length of 26 to 29 mm. Am J Obstet Gynecol. 2021 08; 225(2):179.e1-179.e6.